Nisa Investment Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-44,728
Closed -$8.22K 2371
2021
Q2
$8.22K Sell
44,728
-63,287
-59% -$11.6K 0.05% 314
2021
Q1
$16.5K Buy
108,015
+37,129
+52% +$5.68K 0.1% 192
2020
Q4
$11.1M Sell
70,886
-3,440
-5% -$537K 0.07% 261
2020
Q3
$8.51M Sell
74,326
-14,521
-16% -$1.66M 0.07% 266
2020
Q2
$9.97M Buy
88,847
+12,488
+16% +$1.4M 0.09% 212
2020
Q1
$6.86M Buy
76,359
+46,908
+159% +$4.21M 0.08% 235
2019
Q4
$3.19M Sell
29,451
-6,974
-19% -$754K 0.03% 499
2019
Q3
$3.57M Sell
36,425
-17,325
-32% -$1.7M 0.03% 460
2019
Q2
$7.04M Sell
53,750
-6,665
-11% -$873K 0.07% 287
2019
Q1
$8.17M Buy
60,415
+4,174
+7% +$564K 0.08% 241
2018
Q4
$5.48M Buy
56,241
+2,560
+5% +$249K 0.06% 293
2018
Q3
$7.46M Buy
53,681
+12,616
+31% +$1.75M 0.07% 277
2018
Q2
$5.1M Buy
41,065
+5,870
+17% +$729K 0.05% 344
2018
Q1
$3.97M Buy
35,195
+10,030
+40% +$1.13M 0.04% 403
2017
Q4
$3.01M Sell
25,165
-12,720
-34% -$1.52M 0.03% 486
2017
Q3
$5.32M Buy
37,885
+8,800
+30% +$1.23M 0.06% 313
2017
Q2
$3.34M Sell
29,085
-25,120
-46% -$2.88M 0.04% 426
2017
Q1
$6.57M Buy
54,205
+15,670
+41% +$1.9M 0.08% 265
2016
Q4
$4.72M Buy
38,535
+12,675
+49% +$1.55M 0.06% 332
2016
Q3
$3.17M Buy
25,860
+25
+0.1% +$3.06K 0.04% 421
2016
Q2
$3.02M Sell
25,835
-2,515
-9% -$294K 0.04% 428
2016
Q1
$3.95M Buy
28,350
+2,150
+8% +$299K 0.06% 345
2015
Q4
$5M Buy
26,200
+19,800
+309% +$3.78M 0.07% 274
2015
Q3
$1.02M Buy
6,400
+1,000
+19% +$159K 0.02% 726
2015
Q2
$976K Sell
5,400
-900
-14% -$163K 0.01% 784
2015
Q1
$1.09M Sell
6,300
-350
-5% -$60.7K 0.02% 762
2014
Q4
$1.23M Sell
6,650
-200
-3% -$37K 0.02% 714
2014
Q3
$1.14M Sell
6,850
-300
-4% -$49.8K 0.02% 729
2014
Q2
$1.12M Buy
7,150
+400
+6% +$62.5K 0.02% 762
2014
Q1
$1.03M Hold
6,750
0.01% 782
2013
Q4
$897K Buy
6,750
+3,000
+80% +$399K 0.01% 838
2013
Q3
$436K Sell
3,750
-100
-3% -$11.6K 0.01% 1058
2013
Q2
$355K Buy
+3,850
New +$355K 0.01% 1114